A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...
Moderna Inc. fell in premarket trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.
Moderna shares fell over 4% after the FDA signaled stricter vaccine approval rules, raising concerns about potential delays ...
An HPV vaccine delivered into the nose can treat cervical tumors in mice. The vaccine targets a cancer protein produced by the virus.
Shares in major COVID-19 vaccine makers fell on Monday after an internal U.S. Food and Drug Administration (FDA) memo reportedly suggested that vaccinations may have contributed to several child ...
Press Release - Deal secures more accessible future price per dose, resulting savings of up to US$ 90 million Savings expected to help secure 30 million additional doses, protecting up to 7 million mo ...
Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald initiated coverage of Novavax, Inc. (NASDAQ:NVAX) with an Overweight rating and a ...
Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. The Gaithersburg, Maryland-based ...
Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine. • NVAX stock is showing ...
The FDA has issued a long-awaited approval of Novavax's COVID-19 vaccine (Nuvaxovid), but with unusual restrictions. Novavax makes the nation's only traditional protein-based coronavirus vaccine -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback